Pharma channel feed

Mer­ck touts new da­ta for break­through pneu­mo­coc­cal vac­cine as it heads to PhI­II tri­als

3 years ago
R&D

#Can­nes­Lions2022: J&J and Bay­er nab health and well­ness wins in tech-filled cat­e­go­ry

3 years ago
Marketing

#Can­nes­Lions2022: Phar­ma cre­ativ­i­ty awards shine spot­light on Hori­zon, Evofem and Ab­bott

3 years ago
Marketing

WTO's IP waiv­er for vac­cines is out and the re­sponse is gen­er­al­ly neg­a­tive — from all sides

4 years ago
Coronavirus

Push­ing for top spot in Big Phar­ma, Ab­b­Vie lands a key ap­proval for its block­buster Skyrizi

4 years ago
FDA+

Gal­der­ma kicks off aes­thet­ics brand cam­paign at New York City Pride­Fest

4 years ago
Marketing

J&J inks clin­i­cal tri­al deal with Stand Up To Can­cer, lat­est phar­ma to join can­cer non­prof­it study ef­forts

4 years ago
Marketing

Rhythm gets sec­ond OK for ge­net­ic obe­si­ty drug Im­civree, swings in­to roy­al­ty deal

4 years ago
Deals
FDA+

Up­dat­ed: Mer­ck look­ing at Seagen takeover bid in the wake of Clay Sie­gal­l's res­ig­na­tion — re­port

4 years ago
Deals

FDA au­tho­rizes Pfiz­er, Mod­er­na Covid-19 vac­cines for chil­dren as young as 6 months

4 years ago
FDA+
Coronavirus

Glob­al health of­fi­cials are search­ing for a new name for mon­key­pox as sci­en­tists warn against stig­ma­tiz­ing the virus

4 years ago

FTC tar­gets in­sulin, threat­en­ing to go af­ter PBM-phar­ma deals that steer in­to 'com­mer­cial bribery'

4 years ago

Abu Dhabi's health de­part­ment taps Sanofi in clin­i­cal re­search and AI screen­ing deal

4 years ago
Deals

Men­tal health cri­sis fol­lows Covid pan­dem­ic in US, but phar­ma miss­ing con­nec­tions to younger gen­er­a­tions, study finds

4 years ago
Marketing

Bio­gen Foun­da­tion dou­bles down on next gen­er­a­tion STEM neu­ro­science to kick off its next decade

4 years ago
Marketing

Supreme Court rules in fa­vor of hos­pi­tals over Medicare re­gard­ing 340B re­im­burse­ment pol­i­cy

4 years ago
Law

Mak­e­na's ac­cel­er­at­ed ap­proval with­draw­al hear­ing set for Oc­to­ber as Co­vis wants to do more re­search

4 years ago
FDA+

Pharm­Stars dig­i­tal health match­mak­er adds Roche to phar­ma spon­sor team as it preps a new chal­lenge

4 years ago
Marketing

Sh­iono­gi to pro­vide glob­al ac­cess to its an­tibi­otics, with fo­cus on poor coun­tries, as re­sis­tance fears grow

4 years ago
Deals
Manufacturing

Brook­ings is­sues rec­om­men­da­tions for gener­ic drug com­pe­ti­tion as PDU­FA VI ex­pi­ra­tion looms

4 years ago

Cannes Li­ons 2022: Phar­ma and health cre­atives ea­ger to re­turn in per­son, ready to min­gle with main­stream ad crowd

4 years ago
Marketing

Mar­ket­ingRx roundup: Pfiz­er keeps spot­light on JAKs with Cib­in­qo TV ad; Dex­com amps di­a­betes aware­ness in UK ef­fort

4 years ago
Marketing

Lil­ly's Olu­mi­ant gets new FDA ap­proval, nab­bing a land­mark green­light for au­toim­mune hair loss dis­ease

4 years ago
FDA+

In draft re­port, ICER says Amy­lyx's ALS drug would not be cost ef­fec­tive if priced sim­i­lar­ly to old­er treat­ment

4 years ago
R&D
First page Previous page 193194195196197198199 Next page Last page
A service from the Financial Times